Objectives: Phytocannabinoids, such as THC and endocannabinoids, are well known to promote feeding behavior and to control energy metabolism through cannabinoid type 1 receptors (CB 1 R). However, the underlying mechanisms are not fully understood. Generally, cannabinoidconducted retrograde dis-inhibition of hunger-promoting neurons has been suggested to promote food intake, but so far it has not been demonstrated due to technical limitations. Methods: We applied immunohistochemical labeling of CB 1 R for light microscopy and electron microscopy combined with three-dimensional reconstruction from serial sections in CB 1 R-expressing and CB 1 R-null mice, which served as a negative control. Hunger-promoting neurons expressing Agouti-related protein and neuropeptide Y (AgRP/NPY) in the hypothalamic arcuate nucleus were identified in NPY-GFP and NPY-hrGFP mice.
INTRODUCTION
Regulation of food intake and energy consumption is a complex system that includes multiple regulations of brain and peripheral organs [1e 4]. As a group of lipid messengers, endocannabinoids (eCBs) have the capability to induce synaptic plasticity by retrograde modulation of glutamatergic and GABAergic neurotransmission in various brain areas as well as represent important metabolic signaling molecules in peripheral organs [1, 5, 6] . Indeed, cannabinoid type 1 receptors (CB 1 R) are well known to mediate the effects of cannabinoids on energy metabolism [7e10] . Novel data indicate that the anorexigenic proopiomelanocortin (POMC) neurons reverse their function in the presence of cannabinoids [11, 12] . However, the cellular and molecular mechanisms behind hypothalamic CB 1 R activation in order to regulate energy expenditure and feeding behavior are still not fully understood [10, 13] . POMC neurons affect whole body energy metabolism in tandem with neurons in the hypothalamic arcuate nucleus (ARC) that coexpress Agouti-related protein (AgRP) and neuropeptide Y (NPY; [14] ). At times of negative energy balance, AgRP/NPY neurons are directly activated by the appetite-inducing hormone ghrelin and by increased levels of free fatty acids that are utilized in these neurons via betaoxidation [15] . Upon activation, AgRP/NPY neurons release neuropeptides as well as GABA to control behavior, in part by inhibiting POMC neurons in the ARC [16] . In parallel to the feeding-promoting hormone ghrelin, distinct eCBs such as 2-arachodonoylglycerol (2-AG) are up regulated in the hypothalamus during fasting, whereas satiety-promoting hormones such as leptin acutely reduce hypothalamic 2-AG levels [7, 17, 18] . This prandial state-dependent fluctuation of the retrograde messenger 2-AG indicates that eCBs might be involved in regulation of hypothalamic AgRP/NPY neurons. Previous studies demonstrated moderate amounts of radioactive CB 1 R ligand binding as well as CB 1 R mRNA in hypothalamic nuclei [13,19e21] . However, AgRP/NPY neurons do not contain CB 1 R mRNA and it is thus unlikely that cannabinoids directly affect the output synapses of AgRP/ NPY neurons [19] . Nevertheless, retrograde eCB modification of presynaptic CB 1 R on glutamatergic or GABAergic axon terminals innervating AGRP/NPY neurons was suggested as a putative mechanism of eCB-dependent control of AgRP/NPY activity, but CB 1 R immunolabeling remained uncertain in the ARC [6,22e24] . This inspired our immunohistochemical investigation of eCB signaling in the ARC. Here, we used transgenic mouse models and methods of electron microscopy combined with three-dimensional (3D) reconstruction from serial sections to evaluate the morphological substrate of presynaptic CB 1 Rdependent control of AgRP/NPY neurons in the ARC. [25] . NPY-GFP (B6.Cg-Tg(Npy-MAPT/Sapphire)1Rck/J, stock no 008321, The Jackson Laboratories, Bar Harbor, ME USA) and NPY-hrGFP (B6.FVBTg(Npy-hrGFP)1Lowl/J, stock no 006417, The Jackson Laboratories) mice were used for identification of AgRP/NPY neurons in the ARC. Both lines were maintained on a C57/BL6 background.
Immunohistochemistry for electron and light microscopy
For correlative light/electron microscopy,
À/ À and NPY-GFP mice were perfused transcardially with a fixative containing 4% paraformaldehyde, 0.2% picric acid, and 0.2% glutaraldehyde in 0.1 M PB. The brains were removed and immersed overnight in the same fixative. Coronal brain sections (of 50 mm thickness) were cut with a vibratome. About half of the brain sections were immersed in 0.5% H 2 O 2 for 30 min to block tissue peroxidase, whereas the remaining specimens were used for immunohistochemistry omitting this step. No difference in the immunolabeling was observed between these sections. For single immunolabeling, the sections were incubated with polyclonal sera against CB 1 R raised in guinea pig (1:1000; CB1-GP-Af530; Frontier Institute, Ishikari, Hokkaido, Japan), then, with biotinylated anti-guinea pig IgGs (1:300; Jackson Immunoresearch, West Grove, PA, USA) and the Elite ABC kit (Vector Laboratories, Burlingame, CA, USA) with Ni-intensified 3,3ʹ-diaminobenzidine-4HCl (DAB-Ni) as a chromogen. For CB 1 R/GFAP and CB 1 R/NPY-GFP double labeling, the sections were first immunolabeled for CB 1 R as above with DAB-Ni as a chromogen that produces intensive black staining; then, the sections were incubated with madein-rat anti-GFAP (1:6000; Invitrogen, Eugene, OR, USA) or made-inchicken anti-GFP (1:2000; Thermo Fisher Scientific, Rockford, IL, USA) sera. Thereafter, corresponding biotinylated anti-rat or antichicken IgGs (1:300; both from Jackson Immunoresearch) and the Elite ABC kit were applied as above. 3,3ʹ-diaminobenzidine-4HCl (DAB) producing diffuse electron-dense staining was used as a chromogen. The sections were post-fixed with 1% OsO 4 , dehydrated, embedded in durcupan (Fluka, Buchs, Switzerland) on microscope slides, and coverslipped. Selected fragments of tissue were analyzed and photographed with an Axioplan 2 microscope (Zeiss, Jena, Germany) and re-embedded into durcupan blocks for electron microscopic investigation. The samples were cut with a Reichert ultramicrotome into 70-nm-thick sections. The sections were then stained with lead citrate and evaluated and photographed in a JEM 1010 electron microscope (JEOL, Japan) equipped with a Multiscan 792 digital camera (Gatan, Pleasanton, CA, USA). For 3D reconstruction, 20e30 serial images were made with 15,000Â magnification of electron microscope. Neuropil fragments were chosen for the 3D reconstruction of axon-like processes in a random manner while avoiding cell bodies and blood vessels when possible. The micrographs were aligned using the computer program Reconstruct [26] , publicly available at http://www.bu.edu/neural/Reconstruct.html. conjugate; both from Thermo Fischer Scientific, Waltham, MA, USA) both at a dilution of 1:500 for 1 h at room temperature. Finally, the sections were coverslipped in DAKO mounting medium and confocal laser scanning microscopy was performed using a Zeiss LSM Meta 510.
In previous studies, we extensively analyzed specificity of the anti-CB 1 R labeling using mass-spectrometry, Western Blots, and immunohistochemistry at light and electron microscopy levels; we demonstrated that anti-CB 1 R IgG (CB1-GP-Af530; Frontier Institute) in parallel to CB 1 R also recognize a conformational epitope in mitochondrial stomatin-like protein 2 [27e29]. Specific anti-DAGL labeling (neuronal somato-dendritic surface expression) was confirmed for immunohistochemistry at levels of light and electron microscopy using wild type and DAGL-null mice [30e32]. Specific anti-GFP and anti-GFAP labeling was confirmed in numerous studies [e.g., [33, 34] ].
Statistical analysis
Quantifications of the anti-CB 1 R immunolabeling in identified cell segments and organelles in ARC of the CB 1 R-expressing (CB 1 R þ/þ and CB 1 R þ/À , pooled) and CB 1 R À/À mice were performed at 15,000Â magnification of electron microscope. Percentages of the anti-CB 1 R immuno-precipitation locations in axon-like, dendro-somatic, and mitochondrial profiles were calculated for every measurement. Then, averages of 4 measurements from every one of 4 animals in each group AESD were calculated using Excel 2013 (Microsoft) software. Additional evidence of selective labeling in the CB 1 R-expressing animals was obtained with quantification of the sites of DAB-Ni immunoprecipitations in electron microscopy. Analysis of occasional single ultrathin sections shows that 82.2 AE 4.2% of the immunoprecipitations in the CB 1 R-expressing mice are located in axon-like processes, whereas the remaining number of immuno-precipitations is distributed between dendrites, cell bodies, and mitochondria ( Figure 1G ). Predomination of a certain location of anti-CB 1 R labeling was not encountered in CB 1 R À/À mice. In those, non-CB 1 R binding of the CB 1 R antibodies (presumed background or labeling of other molecules) was detected in nearly equal proportions in axon-like processes, dendro-somatic cell segments, and mitochondria ( Figure 1H ). Mind that similar mitochondrial labeling is evident in the CB 1 Rexpressing and CB 1 R À/À mice, confirming previously demonstrated binding of the anti-CB 1 R serum with mitochondrial stomatin-like protein 2 rather than revealing mitochondrial location of CB 1 R [27e29].
RESULTS

CB 1 R concentrates in axon-like processes in the ARC
In three random segments of ARC neuropil from CB 1 R þ/þ mice that were subject of electron microscopy analysis and 3D reconstruction (each analyzed volume w100 mm 3 ), we identified in total 32, 26, and 13 CB 1 R-positive axon-like processes per a reconstructed segment (Supplementary Figure 2) . No dendrite-like processes containing CB 1 R accumulation were observed in these neuropil segments. Detected CB 1 R-positive axon-like processes are separated by immunonegative tissue and do not form CB 1 R-enriched bundles that would be easily identifiable with light microscopy. Thus, our quantitative electron microscopy analysis and 3D reconstruction from serial sections demonstrate numerous CB 1 R-positive axon-like processes in the hypothalamus.
CB 1 R-expressing axons innervate AgRP/NPY-positive and -negative neurons
To analyze whether the hypothalamic CB 1 R-expressing axons could produce synapses innervating AgRP/NPY neurons in the ARC, we performed double immunolabeling for CB 1 R and GFP in the NPY-GFP transgenic mice. Using 3D reconstruction from serial sections, we detected CB 1 R-positive synapses innervating NPY-GFP-positive dendrites (Figure 2AeC ). Among five identified synapses, all were of symmetric morphological type, indicating that inhibitory GABAergic inputs probably predominate among CB 1 R-positive synapses that innervate AgRP/NPY neurons. In contrast, NPY-GFP-negative dendritic shafts and cell bodies show both symmetric and asymmetric synaptic contacts with CB 1 R-immunopositive axons ( Figure 2D , E and Figure 3) . Thus, CB 1 R-containing synapses innervate AgRP/NPY and other neurons, supporting the hypothesis for retrograde eCB signaling in the ACR and predomination of eCB-conducted dis-inhibition of the AgRP/ NPY hunger promoting neurons. Further morphological study (for example, immuno-gold labeling that provides more precise location of the antigen) of CB 1 R location in the hypothalamic nuclei is warranted.
3.3. CB 1 R and DAGL are co-localized at AgRP/NPY neurons in ARC To further elucidate potential CB 1 R signaling in ARC, we performed immunofluorescence assay for the enzyme DAGL, which is known to be located at postsynaptic sites catalyzing biosynthesis of the eCB retrograde messenger 2-AG [38, 39] . We observed dotted DAGL immunolabeling as in GFP-expressing AgRP/NPY neurons so in GFPnegative cells. Multiple immunofluorescence exemplified a close spatial relationship between CB 1 R and DAGL in the ARC, particularly at NPY-GFP neurons (Figure 4 ). The latter finding supports a retrograde mode of action of 2-AG at AgRP/NPY neurons, as has been demonstrated in other brain segments [5, 29] .
DISCUSSION
Relatively low anti-CB 1 R immuno-reactivity in the hypothalamus makes identification of CB 1 R-containing axons with light microscopy and in single electron micrographs difficult. Here, we addressed this problem using electron microscopy with 3D reconstruction from serial sections. We show that (1) numerous axons in ARC contain several discontinuous CB 1 R-positive segments; (2) CB 1 R-positive axons innervate AgRP/NPY neurons with mostly symmetric, presumed inhibitory, synapses; (3) unlabeled neurons receive both symmetric and asymmetric synaptic contacts with CB 1 R-positive axons; (4) DAGL e the enzyme catalyzing biosynthesis of the eCB retrograde messenger 2-AG e is in close apposition to CB 1 R at AgRP/NPY neurons. Taken together, the data demonstrate the morphologic substrate for eCB/CB 1 R-conducted retrograde dis-inhibition of the orexigenic neurons in ARC. CB 1 R and eCBs were shown to be involved in the regulation of food intake and energy consumption in several hypothalamic nuclei, including the lateral and dorsomedial hypothalamus as well as ARC and paraventricular nucleus [1, 2, 11, 13, 19, 40, 41] . Moreover, eCB prandial regulation apparently includes synaptic and non-synaptic mechanisms [10, 12, 42] . A hypothalamic role of CB 1 R-containing synapses in eCB regulation of food intake was suggested [19, 22] , but it was not experimentally demonstrated. Our findings unravel a yet unknown synaptic mechanism of eCB control of food intake that may act in parallel with recently demonstrated intracellular eCB control of mitochondrial respiration [12] . Thus, our results show that eCBs and cannabis drugs may conduct prandial mechanisms through retrograde synaptic dis-inhibition and dis-excitation in the hypothalamus. Further investigations are warranted to determine the location and neurochemical properties of CB 1 R-expressing inhibitory neurons innervating AgRP/NPY neurons in ARC; and, to determine what neurons provide the CB 1 R-containing inputs to other neurons of the hypothalamus. 
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